GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1A (A8XYX2)

Analyse AlphaFold monomer V2.0 prediction for cap-specific mRNA… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A8XYX2
Type
protein
Length
874 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xF5183B7F8b5C47bB916c44D76C94a3f60767809e
Molecule
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1A
UniProt
A8XYX2
Pockets
12 · best druggability 0.76

Structure

1 distinct chain · 37% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1Aprotein87437% helix, 18% strandA8XYX2

Pockets

12 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15370.760.8342empty
211040.760.7881empty
31140.760.9619empty
41630.650.8633empty
52910.550.7634empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.